• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[无皮下电极植入胸部区域的自动经静脉除颤器的中期临床经验]

[Medium-term clinical experience with automatic transvenous defibrillators implanted in the chest area without subcutaneous electrodes].

作者信息

Favale S, Dicandia C D, Barletta A, Forleo C, Luzzi G, Tunzi P, Rizzon P

机构信息

Istituto di Cardiologia, Università degli Studi, Bari.

出版信息

Cardiologia. 1996 Nov;41(11):1079-87.

PMID:9064205
Abstract

From March 1992 to April 1996 a pectoral biphasic transvenous implantable cardioverter defibrillator without subcutaneous leads was implanted in 35 patients with life threatening ventricular tachyarrhythmias. Mean age was 58 +/- 9 years; 23 patients had coronary artery disease, 10 non ischemic dilated cardiomyopathy and 2 arrhythmogenic right ventricular dysplasia. All were in NYHA functional class I and II and 4 in class III: mean ejection fraction was 35 +/- 12%. The mean duration of the implantation procedure was 85 +/- 35 min. The mean defibrillation threshold, measured in 23 active-CAN devices was 8.8 +/- 5 J. There were no operative complications except in one case of transient ischemic electromechanical dissociation. The mean hospital stay from the time of implant to predischarge evaluation was 6.2 +/- 2 days. The average follow-up period was 18.5 +/- 11 months. Two patients had non sudden and non arrhythmic cardiac death in the third and sixth month, respectively. In 19 patients 171 implantable cardioverter defibrillator interventions were reported: in 5 patients five inappropriate interventions were reported and in the remaining 14 were reported: 35 ventricular fibrillation and 131 ventricular tachycardia. The short duration of the procedure, brief hospitalization with very low perioperative morbidity, high efficacy and low mid-term complications give a new image to this therapeutic option.

摘要

1992年3月至1996年4月,35例有危及生命的室性快速性心律失常的患者植入了无皮下导线的双相胸壁经静脉植入式心脏复律除颤器。平均年龄为58±9岁;23例患者患有冠状动脉疾病,10例患有非缺血性扩张型心肌病,2例患有致心律失常性右心室发育不良。所有患者均处于纽约心脏协会(NYHA)心功能I级和II级,4例为III级:平均射血分数为35±12%。植入手术的平均持续时间为85±35分钟。在23台有源CAN装置中测量的平均除颤阈值为8.8±5焦耳。除1例短暂性缺血性电机械分离外,无手术并发症。从植入到出院前评估的平均住院时间为6.2±2天。平均随访期为18.5±11个月。两名患者分别在第三个月和第六个月发生非猝死性和非心律失常性心脏死亡。19例患者报告了171次植入式心脏复律除颤器干预:5例患者报告了5次不适当干预,其余14例报告了:35次心室颤动和131次室性心动过速。手术时间短、住院时间短、围手术期发病率极低、疗效高和中期并发症低,为这种治疗选择赋予了新的形象。

相似文献

1
[Medium-term clinical experience with automatic transvenous defibrillators implanted in the chest area without subcutaneous electrodes].[无皮下电极植入胸部区域的自动经静脉除颤器的中期临床经验]
Cardiologia. 1996 Nov;41(11):1079-87.
2
Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.胸壁单极植入式心脏复律除颤器的多中心经验。主动除颤电极导线研究者。
J Am Coll Cardiol. 1996 Aug;28(2):400-10.
3
[The implantable cardioverter-defibrillator: the Portuguese experience].[植入式心脏复律除颤器:葡萄牙的经验]
Rev Port Cardiol. 1997 Apr;16(4):367-74, 351-2.
4
[Transvenous cardioverter-defibrillators: clinical experience at implantation and follow-up].[经静脉心脏复律除颤器:植入及随访的临床经验]
Cardiologia. 1995 Jun;40(6):381-9.
5
[Experience with a transvenous pacemaker-cardioconverter-defibrillator without subcutaneous patch].[经静脉起搏器-心脏转复除颤器无皮下贴片的经验]
Orv Hetil. 1995 Feb 5;136(6):299-304.
6
[Implantable defibrillators in the management of malignant ventricular tachyarrhythmias. Experience at the Arrhythmia National Center].[植入式除颤器在恶性室性心律失常治疗中的应用。国家心律失常中心的经验]
Rev Med Chil. 1998 Jul;126(7):803-13.
7
Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads.皮下植入式心律转复除颤器(ICD)导线的长期经验:三种不同类型皮下导线的比较
Pacing Clin Electrophysiol. 2004 Oct;27(10):1355-61. doi: 10.1111/j.1540-8159.2004.00639.x.
8
Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.植入式心脏复律除颤器治疗的年龄依赖性疗效:11年间450例患者的观察结果
Heart. 1997 Oct;78(4):364-70.
9
[14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].[植入式心脏复律除颤器的14年经验:预后和出院行为的判定]
Z Kardiol. 2000;89 Suppl 3:194-205.
10
Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.植入式心脏复律除颤器治疗预防致心律失常性右室心肌病/发育不良患者猝死。
Circulation. 2003 Dec 23;108(25):3084-91. doi: 10.1161/01.CIR.0000103130.33451.D2. Epub 2003 Nov 24.